1Bardeesy N,de Pinho RA. Pancreatic cancer biology and genetics [J]. Nat Rev Cancer, 2002,2 ( 12 ) : 897-909.
2Suzuki A, Shibata T, Shimada Y, et al. Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization [ J ]. Cancer Sci, 2008,99 (5) : 986-994.
3Nalepa G, Rolfe M, Harper JW. Drug discovery in the ubiquitin-proteasome system [J].Nature Reviews. Drug Discovery,2006,5 (7): 596-613.
4Glasgow E, Mishra L. Transforming growth factor-beta signaling and ubiquitinators in cancer[J]. Endocr Relat Cancer,2008,15 (1): 59-72.
5Izzi L,Attisano L. Ubiquitin-dependent regulation of TGF beta signaling in cancer [J ]. Neoplasia, 2006,8 ( 8 ) : 677-688.
6Bashyam MD,Bair R,Kim YH,et al. Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer [J]. Neoplasia,2005,7 (6) :556-562.
7Wang X, Trotman LC, Koppie T, et al. NEDD4-1 is a protooncogenic ubiquitin ligase for PTEN [J]. Cell, 2007, 128(1): 129-139.
8Fire A, Xu S, Montgomery MK, et ol. Potent and sepeeific genetic interference by doule-stranded RNA in Caenorhab- ditis elegans [J]. Nature, 1998, 391(6669): 806-811.
9Matzke M, Matzke A, Kooter JM. RNA: Guiding gene Silencing [J]. Science, 2001, 293(5532): 1080-1083.
10Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells [J]. Science, 2002, 296(5567): 550-553.
